S
UTHR icon

SignatureFD’s United Therapeutics UTHR Stock Holding History

SignatureFD’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$580K Buy
978
+82
+9% +$40.8K 0.01% 553
2025
Q4 		$437K Buy
896
+35
+4% +$16.3K 0.01% 653
2025
Q3 		$361K Buy
861
+251
+41% +$84.4K 0.01% 703
2025
Q2 		$175K Buy
610
+14
+2% +$4.18K ﹤0.01% 978
2025
Q1 		$184K Sell
596
-67
-10% -$23K ﹤0.01% 923
2024
Q4 		$234K Buy
663
+30
+5% +$11K ﹤0.01% 797
2024
Q3 		$227K Buy
633
+51
+9% +$17.2K ﹤0.01% 811
2024
Q2 		$185K Buy
582
+109
+23% +$28.8K ﹤0.01% 846
2024
Q1 		$109K Buy
473
+64
+16% +$14.4K ﹤0.01% 1135
2023
Q4 		$89.9K Buy
409
+15
+4% +$3.46K ﹤0.01% 1160
2023
Q3 		$89K Buy
394
+20
+5% +$4.61K ﹤0.01% 1117
2023
Q2 		$82.6K Sell
374
-36
-9% -$7.97K ﹤0.01% 1160
2023
Q1 		$91.8K Buy
410
+69
+20% +$17K ﹤0.01% 1084
2022
Q4 		$94.8K Sell
341
-31
-8% -$7.83K ﹤0.01% 1032
2022
Q3 		$78K Buy
372
+5
+1% +$1.12K ﹤0.01% 1085
2022
Q2 		$86K Buy
367
+9
+3% +$1.83K ﹤0.01% 1051
2022
Q1 		$64K Sell
358
-67
-16% -$12.8K ﹤0.01% 1250
2021
Q4 		$92K Buy
425
+40
+10% +$7.85K ﹤0.01% 1060
2021
Q3 		$71K Buy
385
+16
+4% +$3.15K ﹤0.01% 1133
2021
Q2 		$66K Buy
369
+7
+2% +$1.33K ﹤0.01% 1143
2021
Q1 		$61K Buy
362
+54
+18% +$9K ﹤0.01% 1092
2020
Q4 		$47K Buy
308
+108
+54% +$14.2K ﹤0.01% 1113
2020
Q3 		$20K Sell
200
-121
-38% -$13.3K ﹤0.01% 1381
2020
Q2 		$39K Buy
321
+187
+140% +$21K ﹤0.01% 1059
2020
Q1 		$13K Buy
134
+25
+23% +$2.38K ﹤0.01% 1401
2019
Q4 		$10K Buy
109
+32
+42% +$2.82K ﹤0.01% 1477
2019
Q3 		$6K Buy
77
+1
+1% +$81 ﹤0.01% 1581
2019
Q2 		$6K Sell
76
-722
-90% -$67.5K ﹤0.01% 1550
2019
Q1 		$94K Buy
798
+236
+42% +$27.5K 0.01% 655
2018
Q4 		$61K Sell
562
-490
-47% -$56.8K 0.01% 762
2018
Q3 		$135K Buy
1,052
+243
+30% +$30.1K 0.01% 534
2018
Q2 		$92K Buy
809
+70
+9% +$7.69K 0.01% 640
2018
Q1 		$83K Buy
+739
New +$93.9K 0.01% 598
2016
Q4 		– Sell
-226
Closed -$27K – 1177
2016
Q3 		$27K Buy
226
+192
+565% +$23.1K ﹤0.01% 716
2016
Q2 		$4K Sell
34
-82
-71% -$9.15K ﹤0.01% 1136
2016
Q1 		$13K Buy
116
+93
+404% +$11.8K ﹤0.01% 779
2015
Q4 		$4K Sell
23
-45
-66% -$6.55K ﹤0.01% 963
2015
Q3 		$9K Buy
68
+61
+871% +$9.78K ﹤0.01% 702
2015
Q2 		$1K Hold
7
– – ﹤0.01% 1007
2015
Q1 		$1K Sell
7
-2
-22% -$305 ﹤0.01% 913
2014
Q4 		$1K Hold
9
– – ﹤0.01% 821
2014
Q3 		$1K Sell
9
-70
-89% -$7.22K ﹤0.01% 667
2014
Q2 		$7K Buy
79
+70
+778% +$6.73K ﹤0.01% 534
2014
Q1 		$1K Hold
9
– – ﹤0.01% 735
2013
Q4 		$1K Hold
9
– – ﹤0.01% 678
2013
Q3 		$1K Buy
+9
New +$658 ﹤0.01% 620

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

SignatureFD's UTHR Position: Q1 2026 in Review

SignatureFD increased its United Therapeutics (UTHR) stake by 9.2% in Q1 2026, buying an estimated $40.8K and bringing the position to 978 shares worth $580K. The position accounts for 0.01% of the portfolio, ranked #553.

SignatureFD first reported a position in UTHR in Q3 2013 and has held it in 46 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • SignatureFD held 978 shares of United Therapeutics worth $580K as of Q1 2026.
  • SignatureFD bought 82 United Therapeutics shares in Q1 2026, an estimated $40.8K.
  • United Therapeutics made up 0.01% of SignatureFD's portfolio in Q1 2026, its #553 holding.
  • SignatureFD first reported a position in United Therapeutics in Q3 2013 and has held it in 46 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.